[Respiratory distress syndrome in premature and newborn infants. 2. Therapy of respiratory distress syndrome].
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D001831:Body Temperature; D002021:Buffers; D003091:Colistin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007185:Incubators; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy / Q000628:therapy*; D007234:Infant, Premature; D008297:Male; D008712:Methicillin / Q000627:therapeutic use; D010101:Oxygen Consumption; D010102:Oxygen Inhalation Therapy; D010288:Parenteral Nutrition; D010530:Peritoneal Dialysis; D011113:Polymyxins / Q000627:therapeutic use; D011175:Positive-Pressure Respiration; D012121:Respiration, Artificial; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy / Q000628:therapy*; D014325:Tromethamine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001639:Bicarbonates; D002021:Buffers; D011113:Polymyxins; D014325:Tromethamine; D000667:Ampicillin; D008712:Methicillin; D003091:Colistin
Das Atemnotsyndrom der Frühgeborenen und Neugeborenen. 2. Die Therapie des Atemnotsyndroms.